US2022378950A1PendingUtilityA1

Compounds having rd targeting motifs and methods of use thereof

Assignee: WASHINGTON UNIVERSITY ST LOUISPriority: May 6, 2015Filed: Jul 6, 2022Published: Dec 1, 2022
Est. expiryMay 6, 2035(~8.8 yrs left)· nominal 20-yr term from priority
G01N 33/57525G01N 33/5759A61K 49/0056A61K 49/0032A61K 38/00C07K 7/06A61K 49/0054A61K 51/088G01N 33/57438G01N 33/57492
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compounds that have motifs that target the compounds to cells that express integrins. In particular, the compounds have peptides with one or more RD motifs conjugated to an agent selected from an imaging agent and a targeting agent. The compounds may be used to detect, monitor, and treat a variety of disorders mediated by integrins.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound having the formula:
   R 1 —[X 1   m —R-D-X 2   p ] n —Y—R 2  
   wherein:
 R 1  is a carbocyanine dye or derivative thereof; 
 R 2  is selected from the group consisting of a treatment agent, hydrogen, hydroxyl, NH 2 , hydrocarbyl, and substituted hydrocarbyl; 
 X 1   m —R-D-X 2   p  together form a linear or cyclic peptide; 
 X 1  and X 2  are independently selected from any amino acid residue; 
 m is an integer from 1 to about 10; 
 n is an integer from 1 to about 10; 
 p is an integer from 1 to about 10; and 
 a dash (—) represent a covalent bond.

Join the waitlist — get patent alerts

Track US2022378950A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.